Abacus Planning Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.56M | Sell |
12,127
-1,139
| -9% | -$133K | 0.19% | 68 |
|
|
2026
Q1 | $1.6M | Sell |
13,266
-851
| -6% | -$98.2K | 0.21% | 62 |
|
|
2025
Q4 | $1.49M | Buy |
14,117
+862
| +7% | +$80.9K | 0.2% | 66 |
|
|
2025
Q3 | $1.11M | Sell |
13,255
-582
| -4% | -$47.9K | 0.15% | 77 |
|
|
2025
Q2 | $1.1M | Sell |
13,837
-498
| -3% | -$39.6K | 0.16% | 74 |
|
|
2025
Q1 | $1.29M | Buy |
14,335
+2,310
| +19% | +$216K | 0.23% | 61 |
|
|
2024
Q4 | $1.2M | Buy |
12,025
+47
| +0.4% | +$4.84K | 0.21% | 69 |
|
|
2024
Q3 | $1.36M | Sell |
11,978
-196
| -2% | -$23.3K | 0.24% | 60 |
|
|
2024
Q2 | $1.51M | Buy |
12,174
+1,116
| +10% | +$144K | 0.29% | 50 |
|
|
2024
Q1 | $1.46M | Sell |
11,058
-489
| -4% | -$60.3K | 0.29% | 48 |
|
|
2023
Q4 | $1.26M | Sell |
11,547
-544
| -4% | -$56.5K | 0.27% | 52 |
|
|
2023
Q3 | $1.24M | Sell |
12,091
-937
| -7% | -$101K | 0.3% | 47 |
|
|
2023
Q2 | $1.5M | Buy |
13,028
+1,004
| +8% | +$114K | 0.36% | 41 |
|
|
2023
Q1 | $1.28M | Sell |
12,024
-232
| -2% | -$25K | 0.33% | 50 |
|
|
2022
Q4 | $1.36M | Buy |
12,256
+1,019
| +9% | +$104K | 0.37% | 47 |
|
|
2022
Q3 | $968K | Sell |
11,237
-1,930
| -15% | -$172K | 0.29% | 56 |
|
|
2022
Q2 | $1.2M | Sell |
13,167
-872
| -6% | -$77.3K | 0.35% | 50 |
|
|
2022
Q1 | $1.15M | Sell |
14,039
-136
| -1% | -$10.7K | 0.31% | 58 |
|
|
2021
Q4 | $1.09M | Buy |
14,175
+2,053
| +17% | +$164K | 0.29% | 62 |
|
|
2021
Q3 | $910K | Buy |
12,122
+180
| +2% | +$13.7K | 0.29% | 63 |
|
|
2021
Q2 | $929K | Sell |
11,942
-738
| -6% | -$54.9K | 0.28% | 64 |
|
|
2021
Q1 | $933K | Buy |
12,680
+199
| +2% | +$14.7K | 0.3% | 64 |
|
|
2020
Q4 | $974K | Sell |
12,481
-167
| -1% | -$12.8K | 0.3% | 62 |
|
|
2020
Q3 | $1M | Sell |
12,648
-518
| -4% | -$40.6K | 0.37% | 54 |
|
|
2020
Q2 | $971K | Buy |
13,166
+268
| +2% | +$20.2K | 0.4% | 53 |
|
|
2020
Q1 | $947K | Buy |
12,898
+164
| +1% | +$12.9K | 0.47% | 43 |
|
|
2019
Q4 | $1.1M | Sell |
12,734
-424
| -3% | -$34.8K | 0.51% | 37 |
|
|
2019
Q3 | $1.06M | Buy |
13,158
+2,699
| +26% | +$216K | 0.52% | 39 |
|
|
2019
Q2 | $837K | Hold |
10,459
| – | – | 0.5% | 43 |
|
|
2019
Q1 | $830K | Sell |
10,459
-142
| -1% | -$10.6K | 0.52% | 44 |
|
|
2018
Q4 | $773K | Buy |
+10,601
| New | +$748K | 0.59% | 41 |
|
Other funds holding MRK
Abacus Planning Group's MRK Position: Q2 2026 in Review
Abacus Planning Group reduced its Merck (MRK) stake by 8.6% in Q2 2026, selling an estimated $133K and leaving 12,127 shares worth $1.56M. The position accounts for 0.19% of the portfolio, ranked #68.
Abacus Planning Group first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.6M in Q1 2026. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Abacus Planning Group held 12,127 shares of Merck worth $1.56M as of Q2 2026.
- Abacus Planning Group sold 1,139 Merck shares in Q2 2026, an estimated $133K.
- Merck made up 0.19% of Abacus Planning Group's portfolio in Q2 2026, its #68 holding.
- Abacus Planning Group first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Abacus Planning Group's Merck position peaked at $1.6M in Q1 2026.
- 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.